Identification of biomarker and clarification of resistance mechanism in immune checkpoint inhibitor therapy
Not Applicable
Recruiting
- Conditions
- on-small cell lung cancer Kidney cancer Malignant melanoma Classical Hodgkin's lymphoma Head and neck cancer Gastric cancer Urothelial cancer Microsatellite instability-high (MSI-H) solid tumor
- Registration Number
- JPRN-UMIN000027091
- Lead Sponsor
- Kanagawa Cancer Center Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 560
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Minor (2) Difficult to obtain consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical application to selection of patients to be applied for immunecheckpoint inhibitors or monitoring after treatment
- Secondary Outcome Measures
Name Time Method Identification of new biomarkers